4.7 Article

Inhibition of pyruvate dehydrogenase kinase improves carbohydrate utilization in Nile tilapia by regulating PDK2/4-PDHE1a axis and insulin sensitivity

Journal

ANIMAL NUTRITION
Volume 11, Issue -, Pages 25-37

Publisher

KEAI PUBLISHING LTD
DOI: 10.1016/j.aninu.2022.06.011

Keywords

Dichloroacetate; Glucose utilization; Insulin sensitivity; Nile tilapia; PDK2/4-PDHE1a axis

Funding

  1. National Key R & D Program of China [2018YFD0900400]

Ask authors/readers for more resources

This study investigated the regulatory function of the PDK-PDHE1a axis in glucose metabolism in fish. The results showed that inhibiting PDK can enhance PDHE1a activity and improve glucose catabolism in fish.
Pyruvate dehydrogenase kinases (PDKs)-pyruvate dehydrogenase E1a subunit (PDHE1a) axis plays an important role in regulating glucose metabolism in mammals. However, the regulatory function of PDKs-PDHE1a axis in the glucose metabolism of fish is not well known. This study determined whether PDKs inhibition could enhance PDHE1a activity, and improve glucose catabolism in fish. Nile tilapia fingerlings (1.90 +/- 0.11 g) were randomly divided into 4 treatments in triplicate (30 fish each) and fed control diet without dichloroacetate (DCA) (38% protein, 7% lipid and 45% corn starch) and the control diet sup-plemented with DCA, which inhibits PDKs through binding the allosteric sites, at 3.75 (DCA3.75), 7.50 (DCA7.50) and 11.25 g/kg (DCA11.25), for 6 wk. The results showed that DCA3.75, DCA7.50 and DCA11.25 significantly increased weight gain, carcass ratio and protein efficiency ratio (P < 0.05) and reduced feed efficiency (P < 0.05) of Nile tilapia. To investigate the effects of DCA on growth performance of Nile tilapia, we selected the lowest dose DCA3.75 for subsequent analysis. Nile tilapia fed on DCA3.75 significantly reduced the mesenteric fat index, serum and liver triglyceride concentration and total lipid content in whole fish, and down-regulated the expressions of genes related to lipogenesis (P < 0.05) compared to the control. The DCA3.75 treatment significantly improved glucose oxidative catabolism and glycogen synthesis in the liver, but significantly reduced the conversion of glucose to lipid (P < 0.05). Furthermore, the DCA3.75 treatment significantly decreased the PDK2/4 gene and protein expressions (P < 0.05), accordingly stimulated PDHE1a activity by decreasing the phosphorylated PDHE1a protein level. In addition, DCA3.75 treatment significantly increased the phosphorylated levels of key proteins involved in insulin signaling pathway and glycogen synthase kinase 3b (P < 0.05). Taken together, the present study demonstrates that PDK2/4 inhibition by using DCA promotes glucose utilization in Nile tilapia by activating PDHE1a and improving insulin sensitivity. Our study helps to understand the regulatory mechanism of glucose metabolism for improving dietary carbohydrate utilization in farmed fish. (C) 2022 Chinese Association of Animal Science and Veterinary Medicine. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available